QCM
GILD icon

Quadrant Capital Management’s Gilead Sciences GILD Stock Holding History

Quadrant Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$723K Sell
11,131
-50
-0.4% -$3.26K 0.33% 72
2019
Q3 		$709K Sell
11,181
-1,280
-10% -$83.7K 0.35% 71
2019
Q2 		$842K Sell
12,461
-5,970
-32% -$393K 0.44% 70
2019
Q1 		$1.2M Sell
18,431
-310
-2% -$20.6K 0.66% 57
2018
Q4 		$1.17M Sell
18,741
-1,450
-7% -$101K 0.77% 55
2018
Q3 		$1.56M Buy
20,191
+400
+2% +$30.2K 0.99% 45
2018
Q2 		$1.4M Sell
19,791
-125
-0.6% -$8.83K 1% 47
2018
Q1 		$1.5M Sell
19,916
-117
-0.6% -$9.3K 1.1% 41
2017
Q4 		$1.44M Sell
20,033
-2,513
-11% -$191K 1.01% 46
2017
Q3 		$1.83M Buy
22,546
+248
+1% +$19K 1.35% 35
2017
Q2 		$1.58M Sell
22,298
-787
-3% -$52.4K 1.23% 39
2017
Q1 		$1.57M Hold
23,085
– – 1.27% 36
2016
Q4 		$1.65M Sell
23,085
-8,854
-28% -$658K 1.42% 36
2016
Q3 		$2.53M Buy
31,939
+190
+0.6% +$15.4K 2.14% 17
2016
Q2 		$2.65M Buy
31,749
+1,924
+6% +$171K 2.23% 14
2016
Q1 		$2.74M Buy
29,825
+1,379
+5% +$124K 2.33% 11
2015
Q4 		$2.88M Buy
28,446
+358
+1% +$37.3K 2.33% 7
2015
Q3 		$2.76M Buy
28,088
+2,042
+8% +$227K 2.34% 7
2015
Q2 		$3.05M Buy
26,046
+3,520
+16% +$385K 2.61% 6
2015
Q1 		$2.21M Buy
22,526
+1,703
+8% +$173K 1.9% 20
2014
Q4 		$1.96M Sell
20,823
-425
-2% -$44K 1.69% 27
2014
Q3 		$2.26M Sell
21,248
-150
-0.7% -$14.7K 2.16% 13
2014
Q2 		$1.77M Buy
+21,398
New +$1.67M 1.7% 27

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Quadrant Capital Management's GILD Position: Q4 2019 in Review

Quadrant Capital Management reduced its Gilead Sciences (GILD) stake by 0.45% in Q4 2019, selling an estimated $3.26K and leaving 11,131 shares worth $723K. The position accounts for 0.33% of the portfolio, ranked #72.

Quadrant Capital Management first reported a position in GILD in Q2 2014 and has held it in 23 quarters since. The position peaked at $3.05M in Q2 2015. 1,555 funds tracked by Wall St. Rank hold GILD as of Q4 2019.

  • Quadrant Capital Management held 11,131 shares of Gilead Sciences worth $723K as of Q4 2019.
  • Quadrant Capital Management sold 50 Gilead Sciences shares in Q4 2019, an estimated $3.26K.
  • Gilead Sciences made up 0.33% of Quadrant Capital Management's portfolio in Q4 2019, its #72 holding.
  • Quadrant Capital Management first reported a position in Gilead Sciences in Q2 2014 and has held it in 23 quarters since.
  • Quadrant Capital Management's Gilead Sciences position peaked at $3.05M in Q2 2015.
  • 1,555 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2019.

Based on Quadrant Capital Management's 13F filing for Q4 2019, filed 29 Jan 2020.